Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Invested Capital: 2022-2024

Historic Return on Invested Capital for Xeris Biopharma Holdings (XERS) over the last 1 years, with Sep 2024 value amounting to -0.22%.

  • Xeris Biopharma Holdings' Return on Invested Capital rose 2.00% to -0.22% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.22%, marking a year-over-year increase of 2.00%. This contributed to the annual value of -0.17% for FY2024, which is 4.00% up from last year.
  • According to the latest figures from Q3 2024, Xeris Biopharma Holdings' Return on Invested Capital is -0.22%, which was up 0.64% from -0.22% recorded in Q1 2024.
  • In the past 5 years, Xeris Biopharma Holdings' Return on Invested Capital ranged from a high of -0.22% in Q3 2024 and a low of -0.38% during Q4 2022.
  • Its 3-year average for Return on Invested Capital is -0.26%, with a median of -0.23% in 2023.
  • Data for Xeris Biopharma Holdings' Return on Invested Capital shows a peak YoY climbed of 15bps (in 2023) over the last 5 years.
  • Over the past 3 years, Xeris Biopharma Holdings' Return on Invested Capital (Quarterly) stood at -0.38% in 2022, then increased by 15bps to -0.23% in 2023, then grew by 2bps to -0.22% in 2024.
  • Its Return on Invested Capital was -0.22% in Q3 2024, compared to -0.22% in Q1 2024 and -0.23% in Q4 2023.